129 related articles for article (PubMed ID: 29107859)
1. The effect of the Progesterone-Induced Blocking Factor (PIBF) on E-cadherin expression, cell motility and invasion of primary tumour cell lines.
Balassa T; Berta G; Jakab L; Bohonyi N; Szekeres-Bartho J
J Reprod Immunol; 2018 Feb; 125():8-15. PubMed ID: 29107859
[TBL] [Abstract][Full Text] [Related]
2. Progesterone-induced blocking factor differentially regulates trophoblast and tumor invasion by altering matrix metalloproteinase activity.
Halasz M; Polgar B; Berta G; Czimbalek L; Szekeres-Bartho J
Cell Mol Life Sci; 2013 Dec; 70(23):4617-30. PubMed ID: 23807209
[TBL] [Abstract][Full Text] [Related]
3. Progesterone-induced blocking factor (PIBF) and trophoblast invasiveness.
Miko E; Halasz M; Jericevic-Mulac B; Wicherek L; Arck P; Arató G; Skret Magierlo J; Rukavina D; Szekeres-Bartho J
J Reprod Immunol; 2011 Jun; 90(1):50-7. PubMed ID: 21632119
[TBL] [Abstract][Full Text] [Related]
4. Proliferative and Invasive Effects of Progesterone-Induced Blocking Factor in Human Glioblastoma Cells.
Gutiérrez-Rodríguez A; Hansberg-Pastor V; Camacho-Arroyo I
Biomed Res Int; 2017; 2017():1295087. PubMed ID: 28168193
[TBL] [Abstract][Full Text] [Related]
5. PIBF (progesterone induced blocking factor) is overexpressed in highly proliferating cells and associated with the centrosome.
Lachmann M; Gelbmann D; Kálmán E; Polgár B; Buschle M; Von Gabain A; Szekeres-Barthó J; Nagy E
Int J Cancer; 2004 Oct; 112(1):51-60. PubMed ID: 15305375
[TBL] [Abstract][Full Text] [Related]
6. Expression and modulation of progesterone induced blocking factor (PIBF) and innate immune factors in human leukemia cell lines by progesterone and mifepristone.
Srivastava MD; Thomas A; Srivastava BI; Check JH
Leuk Lymphoma; 2007 Aug; 48(8):1610-7. PubMed ID: 17701593
[TBL] [Abstract][Full Text] [Related]
7. Progesterone-induced blocking factor is hormonally regulated in human astrocytoma cells, and increases their growth through the IL-4R/JAK1/STAT6 pathway.
González-Arenas A; Valadez-Cosmes P; Jiménez-Arellano C; López-Sánchez M; Camacho-Arroyo I
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():463-70. PubMed ID: 25218441
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of Tripartite Motif Containing 28 suppresses the migration, invasion and epithelial-mesenchymal transition in ovarian carcinoma cells through down-regulation of Wnt/β-catenin signaling pathway.
Deng B; Zhang S; Zhang Y; Miao Y; Meng X; Guo K
Neoplasma; 2017; 64(6):893-900. PubMed ID: 28895414
[TBL] [Abstract][Full Text] [Related]
9. Progesterone induced blocking factor isoforms in normal and failed murine pregnancies.
Bogdan A; Polgar B; Szekeres-Bartho J
Am J Reprod Immunol; 2014 Feb; 71(2):131-6. PubMed ID: 24325791
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning and immunologic characterization of a novel cDNA coding for progesterone-induced blocking factor.
Polgar B; Kispal G; Lachmann M; Paar C; Nagy E; Csere P; Miko E; Szereday L; Varga P; Szekeres-Bartho J
J Immunol; 2003 Dec; 171(11):5956-63. PubMed ID: 14634107
[TBL] [Abstract][Full Text] [Related]
11. Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function.
Sarper M; Allen MD; Gomm J; Haywood L; Decock J; Thirkettle S; Ustaoglu A; Sarker SJ; Marshall J; Edwards DR; Jones JL
Breast Cancer Res; 2017 Mar; 19(1):33. PubMed ID: 28330493
[TBL] [Abstract][Full Text] [Related]
12. Human trophoblast cells express the immunomodulator progesterone-induced blocking factor.
Anderle C; Hammer A; Polgár B; Hartmann M; Wintersteiger R; Blaschitz A; Dohr G; Desoye G; Szekeres-Barthó J; Sedlmayr P
J Reprod Immunol; 2008 Oct; 79(1):26-36. PubMed ID: 18817979
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy-associated changes in expression of progesterone receptor and progesterone-induced blocking factor genes in bone marrow of ewes.
Zhang LY; Mi H; Yan JK; Yan XX; Yang L
Anim Reprod Sci; 2017 Nov; 186():77-84. PubMed ID: 28947097
[TBL] [Abstract][Full Text] [Related]
14. Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis.
Klymenko Y; Kim O; Loughran E; Yang J; Lombard R; Alber M; Stack MS
Oncogene; 2017 Oct; 36(42):5840-5851. PubMed ID: 28628116
[TBL] [Abstract][Full Text] [Related]
15. Progesterone-induced blocking factor (PIBF) influences the expression of membrane progesterone receptors (mPRs) on peripheral CD4
Rafiee M; Rezaei A; Alipour R; Sereshki N; Motamedi N; Naseri M
Hormones (Athens); 2021 Sep; 20(3):507-514. PubMed ID: 33914290
[TBL] [Abstract][Full Text] [Related]
16. Plakoglobin Reduces the in vitro Growth, Migration and Invasion of Ovarian Cancer Cells Expressing N-Cadherin and Mutant p53.
Alaee M; Danesh G; Pasdar M
PLoS One; 2016; 11(5):e0154323. PubMed ID: 27144941
[TBL] [Abstract][Full Text] [Related]
17. Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression.
Kokenyesi R; Murray KP; Benshushan A; Huntley ED; Kao MS
Gynecol Oncol; 2003 Apr; 89(1):60-72. PubMed ID: 12694655
[TBL] [Abstract][Full Text] [Related]
18. The interplay between intracellular progesterone receptor and PKC plays a key role in migration and invasion of human glioblastoma cells.
Marquina-Sánchez B; González-Jorge J; Hansberg-Pastor V; Wegman-Ostrosky T; Baranda-Ávila N; Mejía-Pérez S; Camacho-Arroyo I; González-Arenas A
J Steroid Biochem Mol Biol; 2017 Sep; 172():198-206. PubMed ID: 27717886
[TBL] [Abstract][Full Text] [Related]
19. Cells isolated from human glioblastoma multiforme express progesterone-induced blocking factor (PIBF).
Kyurkchiev D; Naydenov E; Tumangelova-Yuzeir K; Ivanova-Todorova E; Belemezova K; Bochev I; Minkin K; Mourdjeva M; Velikova T; Nachev S; Kyurkchiev S
Cell Mol Neurobiol; 2014 May; 34(4):479-89. PubMed ID: 24474429
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia suppresses E-cadherin and enhances matrix metalloproteinase-2 expression favoring esophageal carcinoma migration and invasion via hypoxia inducible factor-1 alpha activation.
Jing SW; Wang YD; Chen LQ; Sang MX; Zheng MM; Sun GG; Liu Q; Cheng YJ; Yang CR
Dis Esophagus; 2013 Jan; 26(1):75-83. PubMed ID: 22340517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
